glp 1 burping and farting “Sulfur burps” in patients on GLP-1 therapies may be more than a minor side effect. Experts note these symptoms can reflect underlying gastrointestinal changes linked to the drugs’ mechanism of Flatulence from GLP-1 Injections -

Vomiting that persists

Follow-up imaging showed a stable pancreas

By preventing the breakdown of GLP-1 and prolonging its circulation, TEN antinociceptive action was partially counteracted by the GLP-1R antagonist exendin-3, suggesting GLP-1R-independent mechanisms

Food and Drug Administration (FDA), the approved dosages for some of the commonly prescribed GLP-1 agonists are as follows: Semaglutide (Ozempic): 0.5 mg, 1 mg, or 2 mg once weekly for type 2 diabetes, and up to 2.4 mg once weekly for chronic weight management (marketed as Wegovy)

2023;6:e2314493

Ongoing Research and Expansion Pharmaceutical companies continue researching new uses for GLP-1 medications, including potential benefits for cardiovascular health and other chronic conditions